Профиль

Find out what’s needed to give people faster and fairer access to the latest treatments, so they can live longer, healthier lives. Visit: www.abpi.org.uk/reputation/b...

www.abpi.org.uk/media/news/2...

On the resignation of Lord Vallance, Richard Torbett said: “Lord Vallance has been a tremendous Science Minister and a genuine champion for the UK's life sciences sector. He has been instrumental in beginning to turn around international sentiment towards the UK as a life sciences destination."

This landmark agreement between the UK and Switzerland, two nations with a long history of collaboration in life sciences, is built on a shared understanding of what is needed to support innovation and bring new medicines to patients. www.gov.uk/government/n...

Today we have published the latest Disclosure UK data. Disclosure UK records payments & benefits in kind made by pharmaceutical companies to healthcare professionals, healthcare organisations and NHS organisations. Read our latest blog post here: www.abpi.org.uk/media/blogs/...

Today we've gone #Red4Research! 🧬 🔬 🩺 Through industry clinical research, scientific breakthroughs can become life-changing medicines for patients. Thank you to all the scientists, clinicians, & patients who make health and care research happen. 🔴 @nihr.bsky.social @hralatest.bsky.social

The department also plans to launch an alternative approach to consulting on future adjustments, using direct engagement through workshops with industry and patient groups. Importantly, this still includes an option to submit written evidence, ensuring anyone has the opportunity to have their say.

Following a consultation, the Department of Health and Social Care will implement its proposals to reduce the statutory scheme's headline payment percentage for 2026 and beyond to 16.5%, maintaining broad commercial equivalence with the Voluntary Scheme. www.gov.uk/government/c...

Pleased to be supporting the Newcomer of the Year award at this years @absw.bsky.social awards! Good luck to all finalists!

On International Clinical Trials Day, we're highlighting the importance of clinical trials, without which we would have no new medicines or vaccines. Dr Janet Valentine explains below. #ICTD @nihr.bsky.social @hralatest.bsky.social @mhragovuk.bsky.social www.youtube.com/watch?v=PaqV...

Delighted to welcome a new @plaidcymru.bsky.social government under @rhunapiorwerth.bsky.social's leadership. We will continue our work to support equitable access to innovation, drive health & economic ambitions to deliver better health outcomes for people in Wales. www.abpi.org.uk/publications...

📋 New blog from ABPI's Sophie Caseby unpacking the latest EFPIA W.A.I.T. Indicator report. England ranks 7th in Europe for access to newly approved medicines overall — but 14th for cancer treatments. What's driving the gap, and what needs to change? 👇 www.abpi.org.uk/media/blogs/...

Medicines supply issues are relatively rare, but when they happen, they can have a serious impact on patients. Our new report sets out how to improve the supply chain to anticipate risks and respond quickly when disruption occurs. Read more: www.abpi.org.uk/publications...

Decentralised or hybrid clinical trials can bring research closer to home - boosting access & inclusion. A new @acmedsci.bsky.social report, supported by us + @nihr.bsky.social shows how to encourage more of these trials: choice, trust & clearer guidance. acmedsci.ac.uk/file-downloa...

We are celebrating World Immunization Week🎉 Vaccines have safely protected people, families, and communities for generations and as part of our free learning resources for schools you can find out more about the importance of vaccinations with Ellie. www.abpischools.org.uk/topics/ellie...

The panel discussed how co-creation between industry, academia, government and the NHS is essential to remove barriers and expand access to research. #ABPIconf26

Next up is our clinical trials panel! Improvements in regulatory performance, alongside the UK’s unique health data assets, are strengthening the environment for commercial and non commercial clinical trials. For industry, the priorities are clear: predictability, accuracy and speed. #ABPIconf26

The ABPI Exam offers qualifications for industry personnel to have the understanding they need to promote medicines ethically. Each year, we recognise the candidate who has achieved the highest grade. Congratulations to Pedro Figueiredo Aparicio from Johnson & Johnson Innovative Medicine UK! 🎉👏🏆

Panellists pointed to the value of bringing together industry, government, academia and the health system to unlock the UK’s full potential. #ABPIconf26

A strong start to today’s growth panel on where the UK can win globally. The discussion pointed to a clear opportunity for the UK at the intersection of life sciences and AI, with healthcare seen as one of the most promising settings for innovation to flourish. #ABPIconf26